BioSpace News Archive

Business

GT Biopharma Provides Second Quarter 2021 Business Update

GT Biopharma, Inc. today provided a general business update of events in the second quarter ending June 30, 2021.

August 13, 2021
·
8 min read
Medical Tourism Market to Reach $273.72 Billion by 2027 at 12.8% CAGR

Reasonable great quality consideration, open data and care, and backing from government offices and affiliations fuel the development of the worldwide medical tourism market.

August 13, 2021
·
4 min read
Companion Diagnostic Market to Reach $6.45 Billion by 2026 Rising Industry with Immunohistochemistry, PCR, NGS, and others.

Increase in demand for personalized medicine across the regions with increase in popularity of companion diagnostics major drive the market growth.

August 13, 2021
·
4 min read
Infusion Pumps and Accessories Market Will Generate New Growth Opportunities in the next upcoming year

Infusion pumps are medical devices employed to deliver medications and fluids into patient’s body in controlled dosages.

August 13, 2021
·
5 min read
Business

Biostage Reports Q2 2021 Financial Results

Biostage, Inc., a bioengineering company developing next-generation esophageal implants based its novel Cellframe™ and Cellspan™ technology, announced its financial results for the three and six months ended June 30, 2021.

August 13, 2021
·
5 min read
Business

AgeX Therapeutics Reports Second Quarter 2021 Financial Results

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended June 30, 2021.

August 13, 2021
·
10 min read
Relay Certified by Tritan Software; A Health Management Platform for Global Medical Operations Including the Maritime Industry

Tritan is a leading provider of Health and Safety Management software platforms.

August 13, 2021
·
6 min read
Business

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

China Pharma Holdings, Inc., an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, announced the financial results for the quarter ended June 30, 2021.

August 13, 2021
·
9 min read
XORTX Therapeutics Calls Special Meeting of Shareholders - Aug 13, 2021

XORTX Therapeutics Inc., a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce that the Company has called a special meeting of shareholders for 11:00 a.m. on September 2, 2021.

August 13, 2021
·
3 min read
FDA

U.S. FDA Approves TICOVAC™, Pfizer’s Tick-Borne Encephalitis (TBE) Vaccine

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved TICOVAC™ (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1 year of age and older.

August 13, 2021
·
10 min read